Pharmacytimes: Condition Center: Hepatitis C Hepatitis C en-us Fri, 20 Jan 2017 05:55:02 UTC Fri, 20 Jan 2017 05:55:02 UTC Epclusa for Hep C: What Pharmacists Should Know This fixed-dose combination of sofosbuvir and velpatasvir is indicated to treat chronic HCV genotypes 1-6. 9:38 PM, Wed January 4, 2017 Studies in Virology Every Pharmacist Should Know Over the years, a number of landmark clinical studies in virology have been published, shaping how we treat the disease today. 10:35 PM, Tue December 27, 2016 Declining Hepatitis C Sales Reports show that sales and revenue from Hepatitis C treatments are declining. What does this mean for patients? 10:28 PM, Wed November 16, 2016 Pharmacist Charged for Hepatitis C Drug Fraud A former Clinical Pharmacy Manager at a Walgreens specialty pharmacy pleaded guilty to health care fraud crimes committed between October 2014 and April 2016. 8:00 AM, Thu October 27, 2016 5 Highlights from the Pharmacy World This Week In case you missed it, here’s the hottest news in pharmacy this week: 11:13 PM, Thu October 6, 2016 Trouble on the Horizon for Gilead's HCV Market Hold Gilead Sciences—maker of hepatitis C virus blockbusters Sovaldi, Harvoni, and, most recently, Epclusa—has come under increasing scrutiny for declining revenues, both in the near-term and beyond. 3:05 AM, Fri September 2, 2016 Managing Drug Interactions in HIV/HCV-Coinfected Patients Patients taking mediations for both HIV and HCV must be closely monitored for drug-drug interactions. 3:19 AM, Tue August 23, 2016 Zepatier for Hep C: What Pharmacists Should Know This fixed-dose combination of elbasvir and grazoprevir is indicated to treat chronic HCV genotypes 1 or 4 with or without ribavirin in adults. 10:38 PM, Sun August 14, 2016 FDA Approves Hep C Treatment for All Major Genotypes The FDA today approved Gilead Sciences’ sofosbuvir and velpatasvir (Epclusa) for the treatment of adult patients with chronic hepatitis C virus both with and without cirrhosis. 4:25 AM, Tue June 28, 2016 New Indications Approved for Harvoni The FDA has approved Gilead Sciences’ supplemental new drug applications for ledipasvir/sofosbuvir (Harvoni), which can treat chronic hepatitis C patients with advanced liver disease. 7:00 AM, Fri February 19, 2016 Zepatier Approved as Hep C Treatment The FDA has approved Merck’s elbasvir and grazoprevir with or without ribavirin for the treatment of chronic hepatitis C virus genotypes 1 and 4 infections. 7:00 AM, Tue February 2, 2016 HIV Coinfection Doesn't Affect Hep C Treatment Adherence One-third of HIV-infected Americans are co-infected with hepatitis C virus (HCV), and 75% to 90% of HIV-positive intravenous drug users are co-infected. 11:59 PM, Wed January 20, 2016 Hep C Treatment for All Genotypes Granted Priority Review The FDA has given priority review status to a new drug application for Gilead Sciences’ sofosbuvir and velpatasvir as a treatment for chronic genotype 1-6 hepatitis C virus infection. 9:00 PM, Tue January 5, 2016 Once-Daily Viekira Pak Under FDA Review The FDA is taking into consideration a once-daily formulation of AbbVie's ombitasvir, paritaprevir, and ritonavir tablets co-packaged with dasabuvir tablets (Viekira Pak). 7:00 AM, Wed December 9, 2015 Newly Infected HIV Patients Have Low Prevalence of Hep C Co-Infection The World Health Organization indicates that 35 million individuals have HIV worldwide, and 4 to 5 million HIV-infected patients are co-infected with hepatitis C virus. 10:00 PM, Thu December 3, 2015 Merck's Hepatitis C Combination Candidate Receives Priority Review The FDA has granted priority review to Merck's chronic hepatitis C virus (HCV) treatment candidate grazoprevir/elbasvir. 10:00 PM, Fri July 31, 2015 Hepatitis C Combination Therapy Seeks Label Update Janssen is asking the FDA to update the label of its once-daily hepatitis C virus (HCV) drug simeprevir (Olysio). 1:51 AM, Mon July 27, 2015 Medicaid Violations Hinder Hepatitis C Drug Access Many states implement unlawful and life-threatening restrictions on Medicaid coverage for the hepatitis C virus drug, sofosbuvir. 4:00 AM, Sat July 4, 2015 Prescription Payment Caps Enacted in California California's Affordable Care Act health insurance exchange marketplace is the first in the nation to enact a payment cap policy for expensive specialty drugs. 11:51 PM, Sun June 28, 2015 New Drugs Health-System Pharmacists Should Know Here are new drugs for 2015 pharmacists can expect to handle. 12:26 AM, Thu June 18, 2015